CGMIS 48-hour Feasibility Study

CGMIS 48-hour Feasibility Study
Condition:   Type1diabetes
Intervention:   Device: CGMIS (Continuous Glucose Monitoring Infusion Set)
Sponsor:   Pacific Diabetes Technologies

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 1, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine